HH&L Acquisition (NYSE:HHLA – Get Rating) and Viridian Therapeutics (NASDAQ:VRDN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Insider & Institutional Ownership 64.1% of HH&L Acquisition shares […]
HH&L Acquisition Co. (NYSE:HHLA – Get Rating) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 6,500 shares, an increase of 8.3% from the April 15th total of 6,000 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily […]
DiaCarta Receives Accreditation by the College of American Pathologists (CAP) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HH&L Acquisition Co. (NYSE:HHLA – Get Rating) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 6,000 shares, an increase of 9.1% from the March 31st total of 5,500 shares. Based on an average daily trading volume, of 36,000 shares, the days-to-cover ratio […]
HH&L Acquisition (NYSE:HHLA – Get Rating) and Progenity (NASDAQ:PROG – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership. Analyst Recommendations This is a breakdown of recent ratings and […]